News Formal

Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteers

  • 📰 Reuters
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Pfizer Inc and BioNTech SE have proposed to the U.S Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to about 44,000 participants, the companies said on Saturday.

The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.

The proposed expansion would allow the companies to enroll people as young as 16 and people with chronic, stable HIV, hepatitis C and hepatitis B. “As stated previously, based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October,” the companies added in a joint statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

🙄

The CEOs should go first

We are in the World War III of biological weapons(CCP Virus)

I hope when they say 'volunteers' it truly is that and not the usual forced vaccination of poor people in the name of science

Vacancy...44,000 lab rats needed..

Very bad idea don't listen to lying pos trump 🙄

If you need any kind of logo design like a Flat, Minimal, Vintage logo, Please check

44.000 volunteers, every day an idiot and rascals leave the house, when they meet, give business.

New Biotech, check this out!

How much trial do you need ! COVID19

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer proposes expansion of late-stage coronavirus vaccine trialThe companies, which are developing the vaccine together, said in a statement that the trial is proceeding as planned and they expect to have enrolled 30,000 participants by next week. Well done Fairly positive development if they are expanding the trial.
Source: CNBC - 🏆 12. / 72 Read more »

As COVID-19 Vaccine Trials Move At Warp Speed, Recruiting Black Volunteers Takes TimeSome pharmaceutical companies are well into the final phase of clinical trials for a coronavirus vaccine. But efforts to recruit patients from minority groups are just beginning. We have to build public trust based on science and ethics. The book bad blood is a good read on this subject Harkens back to WWII.... When POC were used as guinea pigs.
Source: NPRHealth - 🏆 144. / 63 Read more »